Athira Pharma

Developer of drugs for neurodegenerative diseases

placeSeattle, Washington, United States calendar_todayFounded 2011 groups62 employees language athira.com

Registered entities

Social engagement

Social engagement: 7.4K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

24 investors on record; lead investors include Alzheimer's Drug Discovery, Dolby Family Ventures, Perceptive Advisors, Array.

Investor typeCountShare
Venture capital1042%
Private equity14%
Accelerator & incubator14%
Bank & private debt28%
Other / undisclosed1042%

Recent activity

17 Jun 2026
Event
BIO International Convention 2026
10 Jun 2026
Event
BIO International Convention 2026
27 May 2026
Event
5th Annual ALS Drug Development Summit
Coming soon